Preparation and Drug Loading Performance of Woven Composite Pipe Stents

Literature Overview

This paper investigates the preparation of woven composite pipe stents and evaluates their drug loading performance for biomedical applications. The woven composite stent is fabricated from a combination of metallic and polymer materials, creating a structure that combines the mechanical strength and shape memory properties of metals with the biocompatibility and drug delivery capabilities of polymers. While this topic falls within the biomedical engineering domain, the principles of composite material fabrication, interface bonding, and mechanical performance evaluation are directly relevant to the field of bimetal products and clad plate manufacturing.

Core Technical Points

The woven composite stent under investigation is fabricated by weaving metallic wires, typically nitinol (NiTi) or stainless steel, with polymer fibers, such as polyurethane or polylactic acid (PLA), to create a tubular structure. The weaving pattern, material selection, and processing parameters are critical factors that determine the stent's mechanical properties, drug loading capacity, and biocompatibility.

Material Composition and Properties

Component	Material	Diameter	Key Properties	Function
Metallic wires	Nitinol (NiTi)	0.1-0.3 mm	Shape memory, high strength	Structural support
Metallic wires	316L stainless steel	0.1-0.3 mm	Corrosion resistance	Alternative structural material
Polymer fibers	Polyurethane	0.05-0.15 mm	Biocompatibility, flexibility	Drug carrier
Polymer fibers	PLA	0.05-0.15 mm	Biodegradability	Temporary structural support
Adhesive	Medical-grade epoxy	N/A	Bonding strength	Fiber fixation

The study demonstrates that the woven composite stent exhibits superior mechanical properties compared to monolithic metallic stents, with a radial strength of 8-12 N per mm, a radial compression ratio of 70-80 percent, and a radial recoil of less than 10 percent. The polymer fibers contribute to the drug loading capacity, with a drug loading efficiency of 85-95 percent for model drugs such as sirolimus and paclitaxel.

Drug Loading and Release Performance

The drug loading performance of the woven composite stent is evaluated using standard drug loading and release testing methods. The study employs a drug loading efficiency test and an in vitro drug release test to characterize the stent's drug delivery performance.

Drug Loading and Release Characteristics

Parameter	Value	Test Method	Significance
Drug loading capacity	15-25 μg/cm²	Gravimetric method	Total drug amount
Drug loading efficiency	85-95%	HPLC analysis	Utilization of drug
Initial burst release	10-20% in 24h	In vitro release test	Acute drug delivery
Sustained release duration	30-90 days	In vitro release test	Long-term efficacy
Release profile	Biphasic	In vitro release test	Controlled delivery
Drug retention after 90 days	5-15%	HPLC analysis	Residual drug

The study identifies the polymer fiber composition and the weaving pattern as the primary factors controlling the drug loading and release behavior. A higher polymer fiber content increases the drug loading capacity but reduces the mechanical strength of the stent. The weaving pattern affects the surface area available for drug adsorption and the diffusion path length for drug release.

Fabrication Process and Quality Control

The fabrication of woven composite stents involves several critical process steps including material preparation, weaving, adhesive application, heat treatment, and post-processing. Each step must be carefully controlled to ensure the stent's mechanical properties and drug loading performance meet the required specifications.

Fabrication Process Steps

Step	Process	Critical Parameters	Quality Control
Material preparation	Wire drawing, fiber spinning	Diameter, strength	Dimensional inspection
Weaving	Automated loom weaving	Pattern, tension	Visual inspection
Adhesive application	Dip coating or spray	Thickness, uniformity	Adhesion strength test
Heat treatment	Curing at 60-80°C	Temperature, time	Bond strength verification
Post-processing	Cutting, crimping	Length, diameter	Dimensional inspection
Drug loading	Immersion or coating	Concentration, time	Drug loading efficiency
Sterilization	EtO or gamma irradiation	Dose, cycle	Bioburden testing

The quality control of the woven composite stent involves comprehensive testing of mechanical properties, drug loading performance, biocompatibility, and sterilization efficacy. The study emphasizes the importance of batch-to-batch consistency and the implementation of robust quality management systems in accordance with ISO 13485 medical device quality management requirements.

Engineering Practice Integration

From a materials engineering perspective, the fabrication of woven composite stents offers several insights that are directly applicable to the manufacture of bimetal products and clad plate pressure vessels. The concept of combining metallic and polymeric materials to achieve complementary properties is analogous to the use of clad plate, where a corrosion-resistant overlay is bonded to a structurally strong base metal. The challenges of interface bonding, mechanical compatibility, and long-term performance under service conditions are common to both applications.

The study's emphasis on quality control and process parameter optimization is directly relevant to the fabrication of clad plate pressure vessels, where the bonding quality of the clad interface must be verified through non-destructive testing and mechanical testing. The study's approach to characterizing drug loading and release performance provides a model for the characterization of overlay layer performance in pressure vessel applications, where the corrosion resistance and mechanical integrity of the overlay must be evaluated under simulated service conditions.

Performance Comparison

Property	Monolithic Metal Stent	Woven Composite Stent	Improvement
Radial strength	10-15 N/mm	8-12 N/mm	Comparable
Radial compression	60-70%	70-80%	10-15% improvement
Radial recoil	10-20%	<10%	50% improvement
Drug loading	0-5 μg/cm²	15-25 μg/cm²	Significant
Biocompatibility	Good	Excellent	Improved
Flexibility	Low	High	Significant

Key Questions and Reflections

A critical question that arises from this study is the long-term mechanical stability of the woven composite stent under cyclic loading conditions that simulate the pulsatile blood flow in arteries. The metallic wires are subject to fatigue loading, and the polymer fibers may experience creep deformation under sustained stress. The study provides preliminary data on cyclic loading performance, but the long-term behavior over thousands of loading cycles remains uncertain. This concern is directly analogous to the fatigue performance of clad plate welds in pressure vessels subjected to cyclic pressure loading.

Another important consideration is the biocompatibility of the adhesive used to fix the woven structure. The study identifies medical-grade epoxy as the preferred adhesive, but the long-term biocompatibility of epoxy resins in contact with blood and tissue fluids must be evaluated in accordance with ISO 10993 standards. This consideration is relevant to the selection of welding consumables and fluxes in clad plate fabrication, where the chemical composition of the weld metal and slag must be compatible with the service environment.

Study Insights and Implications

The most significant insight from this literature is the demonstration that woven composite structures can combine the mechanical advantages of metallic materials with the functional advantages of polymeric materials to create high-performance biomedical devices. For engineers working in the field of bimetal products and clad plate manufacturing, the study reinforces the principle that material combination and interface engineering are powerful tools for achieving superior performance. The study also highlights the importance of process control and quality assurance in the fabrication of composite structures, which is directly applicable to the manufacture of clad plate pressure vessels where the bonding quality of the clad interface is critical to the long-term integrity of the product. The systematic approach to material selection, process optimization, and performance evaluation provides a valuable framework for the development of next-generation composite materials and structures in both biomedical and industrial applications.